Management of residual masses in testicular germ cell tumors

Expert Review of Anticancer Therapy
A HeidenreichD Pfister

Abstract

About 50% of all patients with advanced testicular cancer demonstrate residual retroperitoneal or extraretroperitoneal masses. About two thirds of the masses harbour necrosis/fibrosis only whereas as about 10% and 40% harbour vital cancer or teratoma. Appropriate therapy will result in a high cure rate if performed properly. Areas covered: This review article covers the indication, the surgical technique and the oncological outcome of PC-RPLND and resection of extraretroperitoneal residual masses following chemotherapy in patients with advanced testis cancer. Expert commentary: Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) plays an integral part of the multimodality treatment in patients with advanced testicular germ cell tumours. Patients with nonseminomas, residual masses < 1cm and good prognosis can undergo active surveillance. In all other cases, PC-RPLND with or without resection of adjacent organs needs to be performed for curative intent. PC-RPLND requires a complex surgical approach and should be performed in experienced, tertiary referral centres only.

References

Sep 1, 1992·Journal of Surgical Oncology·M R KamatR Ravi
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E L FriedmanJ P Richie
Jul 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S D FossåO Kaalhus
Oct 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M SchultzP J Loehrer
Dec 1, 1988·British Journal of Cancer·R N HitchinsK D Bagshawe
Jun 1, 1982·The Journal of Urology·D G SkinnerG Lieskovsky
Jul 1, 1993·Urology·M J Waples, E M Messing
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S PucR J Motzer
Mar 1, 1997·The Journal of Urology·H W HerrR J Motzer
Nov 24, 1999·Annals of Surgical Oncology·T L HahnR J Goulet
Jul 14, 2000·The Journal of Urology·P AlbersS C Müller
May 9, 2001·The Journal of Urology·S D BeckJ P Donohue
Mar 12, 2003·The Journal of Urology·Wade J SextonLouis L Pisters
May 29, 2003·The Journal of Urology·Ashraf A MosharafaJohn P Donohue
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria De SantisJörg Pont
Apr 13, 2004·The Journal of Urology·Ashraf A MosharafaJohn P Donohue
May 18, 2004·Aktuelle Urologie·P AlbersS Aharinejad
Aug 27, 2004·BJU International·Ellen CopsonGraham Z Mead
Dec 8, 2004·European Urology·Axel HeidenreichJörg Beyer
Apr 20, 2005·European Journal of Radiology·Alexander BechererKurt Kletter
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen D W BeckJohn P Donohue
Apr 22, 2006·European Urology·Ryan K BerglundEric A Klein
Nov 29, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K FizaziG Fromont
Dec 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian KollmannsbergerCraig Nichols
May 17, 2011·Hematology/oncology Clinics of North America·Karin Oechsle, Carsten Bokemeyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.